First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar(R) Gel for Rheumatoid Arthritis

CHESTERFIELD, United Kingdom, Nov. 14, 2016 -- (Healthcare Sales & Marketing Network)-- Mallinckrodt plc (MNK), a leading global specialty biopharmaceutical company, today confirmed enrollment of the first patient in the company's Phase 4 clinical study ...Biopharmaceuticals
Mallinckrodt, H.P. Acthar, corticotropin, rheumatoid arthritis